“Activity of Belinostat in Patients With Recurrent or Refractory Peripheral or Cutaneous T-Cell Lymphoma”. Hematology Meeting Reports, vol. 3, no. 1, June 2009, https://doi.org/10.4081/hmr.v3i1.527.